MarketInOut Stock Screener Log In | Sign Up
 

Glaukos Corp

NYSE • Healthcare • Medical Devices • Quote as of 10/23/2026
Glaukos Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNYSE
Market Capitalization10,422 mln
Float56.64 mln
Earnings Date10/28/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-3.12
Reliable

1-Year Forecast

199.31
Modest upside

Relative Strength

92 / 100
Top performer

Debt / Equity

0.15
Very low leverage

Pre-Tax Margin

-31%
Deeply loss-making

Business Description

Glaukos Corporation is a medical technology and eye care company based in Aliso Viejo, California, that develops treatments for glaucoma, corneal conditions, and retinal diseases across the United States and global markets. The company offers a range of products including tiny implants that help fluid drain from the eye to lower pressure in glaucoma patients, a drug-releasing device placed inside the eye, and a treatment for a condition that causes the cornea to thin and bulge. Glaukos also works on a skin-applied eyelid cream that delivers medication without eye drops, as well as therapies targeting serious retinal diseases such as age-related macular degeneration. Its products are sold to surgery centers, hospitals, and private eye care practices through both direct sales teams and distribution partners.

Key Fundamentals

EPS-3.26
ROE-26.53
RPS10.58
ROIC-12.69
ROA-19.88
Interest Cover-16.41
EBITDA, mln-141
EV / EBITDA-66.45
EV / EBIT-50.03
Revenue, mln613
EV / Revenue15.34

Quote Details

Last 178.88
Change 2.19 (1.24%)
Open 175.95
Volume 961,023
Turnover 171,907,792
Average Volume 956,497

Financial Ratios

Pre-Tax Profit Margin-31
Leverage Ratio1.35
Current Ratio5.04
Price / Book14.02
Price / Tangible Book19.59
Debt / Equity0.15
Price / Sales15.42

Financial Strength

Altman Z-Score22.63
Piotroski F-Score 3 / 9
Beneish M-Score-3.12
1-Year Target Price199.31
Short Ratio4.67
Short % of Float7.91

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.52% 96 / 100   
1 Month 15.5% 96 / 100   
2 Months 15.06% 91 / 100   
6 Months 47.25% 97 / 100   
1 Year 133% 99 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog